TPO and nasopharyngeal carcinoma: Yang et al (39) reported that the use of uninterrupted TPO support for the treatment of two cases of NPC with thrombocytopenia was well-tolerated, and oprelvekin was identified to be effective in the treatment of solid cancer patients with chemotherapy-induced thrombocytopenia (40).